Mechanisms Underlying Individual Variations of Taste and Smell in Obesity

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: Changes to the sense of taste or smell can change eating behavior. This may contribute to obesity. Researchers want to see how taste and smell perceptions that affect food choices may differ between people with obesity and without obesity.

Objective: To understand the role that senses of taste and smell play in food intake.

Eligibility: Adults ages 18-65 with obesity and without obesity

Design: Participants will be screened with a medical history and physical exam. They will have a neurological and sensory exam. They will give blood and urine samples. They will be checked for previous SARS-CoV-2 infection. They will complete questionnaires about their eating habits, alcohol use, and smoking history. Participants will have 2 study visits. Participants will give stool, urine, blood, hair, nasal, and saliva samples. These samples will be used for gene testing. Participants will have their weight, height, and hip and waist circumference measured. They will have an imaging scan that measures body composition. Participants will complete questionnaires about their health, eating habits, and food preferences. Participants will have taste tests and smell tests. They will have sensory tests to assess their response to stimuli. Participants will have a dietary assessment. They will complete a food diary and a diet history questionnaire. Participants will get a meal to eat. Data will be collected about their experience. Participants will complete a sleep diary and wear a watch to measure their activity....

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

⁃ In order to be eligible to participate in this study, an individual must meet all of the following criteria:

• Males and females between 18 to 65 years of age. Due to documented knowledge that taste and smell changes with age, we will limit the cohort within this age range.

• BMI between 18.5 and 29.9 kg/m\^2 for healthy controls or between 30 and 39.9 kg/m\^2 for obese subjects

• Fasted plasma glucose levels between 68-126 mg/dl or per Clinical Center ranges, and hemoglobin A1C\<6.5%

• Able to provide his/her own consent

• Able to understand the protocol, as shown by scoring a 6 out of 6 on a consent quiz

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Nada M Saleh
nada.saleh@nih.gov
(301) 496-3799
Backup
Paule V Joseph, C.R.N.P.
paule.joseph@nih.gov
Time Frame
Start Date: 2022-05-11
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 350
Treatments
Healthy control
BMI of 18.5-29.9 kg/m2
Obese
BMI of 30-39.9 kg/m2
Related Therapeutic Areas
Sponsors
Leads: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

This content was sourced from clinicaltrials.gov